Paxmedica Inc
(OP:
PXMD
)
0.2618
+0.0218 (+9.08%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,199
Open
0.2590
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.2400
Today's Range
0.2301 - 0.2750
52wk Range
0.2000 - 0.5250
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Study Shows Autism More Prevalent in Kids Living in Congested Areas
July 31, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders
July 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Performance
YTD
-29.24%
-29.24%
1 Month
+24.67%
+24.67%
3 Month
-29.24%
-29.24%
6 Month
-29.24%
-29.24%
1 Year
-29.24%
-29.24%
More News
Read More
Women with Autism Have Higher Odds of Being Misdiagnosed with BPD
July 17, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
July 01, 2024
Via
Investor Brand Network
Exposures
Product Safety
New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids
July 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply
June 13, 2024
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development
June 12, 2024
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.